Kulkarni Sadhana S, Tayade Deepak N, Kane Pratibha P, Bhingarde Kiran R, Jain Paramanand N, Futane Savani S, Kelkar Vasanti P, Parchandekar Mukund K, Kulkarni Jyoti V, Prabhu Santosh K, Kaddu Anjali S, Bhosle Deepak S, Deshpande Rajas K, Deshpande Archana S, Shetkar Shubhangi V, Nayak Prabha P, Gunjale Yashoda S, Dhulkhed Pavan V, Kanase Naseema V, Deshmukh Prakash R
Department of Emergency Medicine, MGM Medical College and Hospital, Aurangabad, Maharashtra, India.
Department of Community Medicine and Anaesthesiology, MGM Medical College and Hospital, Aurangabad, Maharashtra, India.
Indian J Anaesth. 2023 Feb;67(Suppl 1):S15-S28. doi: 10.4103/ija.ija_747_22. Epub 2023 Feb 10.
Major complications of central neuraxial block (CNB) are rare and their incidence in India is not known. This information is essential for explaining risk and medico-legal concerns. The present multi-centre study in Maharashtra was conducted to provide insight into the characteristics of rare complications following this popular anaesthetic technique.
Data were collected from 141 institutes to study the clinical profile of CNB. Incidence of complications like vertebral canal haematoma, abscess, meningitis, nerve injury, spinal cord ischaemia, fatal cardiovascular collapse, and drug errors was collected over one year. Complications were reviewed by audit committee to assess causation, severity, and outcome. 'Permanent' injury was defined as death or neurological symptoms persisting for more than six months.
Spinal anaesthesia (SA) was the most frequently used CNB in 88.76% patients. Bupivacaine and an adjuvant were used in 92.90% and 26.06% patients, respectively. Eight major complications (four neurological and four cardiac arrests) were reported in patients receiving SA. In seven of eight instances, SA was responsible or contributory for complication. The pessimistic incidence of complications (included cases where CNB was responsible; contribution was likely, unlikely and could not be commented) was 8.69/lakh and optimistic incidence (included cases where CNB was responsible or contribution was likely) was 7.61/lakh. 'Pessimistically' and 'optimistically' there were three deaths including one death due to quadriplegia following epidural haematoma after SA. Five out of eight patients recovered completely (62.5%). As only eight patients had complications of different types, it was difficult to establish statistical correlation of major complications with demographic or clinical parameters.
This study was reassuring and suggested that the incidence of major complications following CNB was low in Maharashtra.
中枢神经轴索阻滞(CNB)的主要并发症较为罕见,其在印度的发病率尚不清楚。该信息对于解释风险和医疗法律问题至关重要。在马哈拉施特拉邦开展的这项多中心研究旨在深入了解这种常用麻醉技术后罕见并发症的特征。
从141家机构收集数据以研究CNB的临床情况。收集了椎管血肿、脓肿、脑膜炎、神经损伤、脊髓缺血、致命性心血管虚脱及用药错误等并发症在一年中的发病率。审计委员会对并发症进行审查以评估病因、严重程度及结局。“永久性”损伤定义为死亡或神经症状持续超过6个月。
88.76%的患者中最常使用的CNB是脊髓麻醉(SA)。分别有92.90%和26.06%的患者使用布比卡因和一种辅助药物。接受SA的患者中报告了8例主要并发症(4例神经并发症和4例心脏骤停)。在8例中的7例中,SA是并发症的原因或促成因素。并发症的悲观发病率(包括CNB是原因的情况;促成作用可能、不太可能及无法评价)为8.69/10万,乐观发病率(包括CNB是原因或促成作用可能的情况)为7.61/10万。“悲观地”和“乐观地”各有3例死亡,其中1例死亡是由于SA后硬膜外血肿导致四肢瘫痪。8例患者中有5例完全康复(62.5%)。由于只有8例患者出现不同类型的并发症,因此难以确定主要并发症与人口统计学或临床参数之间的统计学相关性。
本研究令人安心,提示在马哈拉施特拉邦CNB后主要并发症的发生率较低。